Capital Change Notice

Capital Change Notice

Updated as at 17 October 2019


Section 1: Issuer information
Name of issuer Third Age Health Services Limited (the
Company)
NZX ticker code TAH
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZTAHE0001S0
Currency NZD

Section 2: Capital change details
Number issued 2,786
Nominal value (if any) N/A
Issue price per security $1.7900
Nature of the payment (for example, cash or other
consideration)
Paid in lieu of a cash dividend
Amount paid up (if not in full) Paid in full
Percentage of total class of Financial Products issued
(calculated on the number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1

0.028%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issue and specific authority for issue (the reason
for change must be identified here)
The shares are issued to shareholders
who opted to join the Dividend
Reinvestment Plan (the Plan), issued 19
May 2022.

The number of shares to be issued is
based on the net dividend payable to
the eligible shareholders and a price of
$1.79. The share price was calculated in
accordance with the Plan, based on the
weighted average sale price for the
shares sold on the NZX Main Board on
each of the first five business days
following the dividend record date.


Total number of Financial Products of the Class after the issue
(excluding Treasury Stock) and the total number of Financial
Products of the Class held as Treasury Stock after the issue.
10,004,149


In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Section 2: Capital change details
Specific authority for the issue, including a reference to the rule
pursuant to which the issue is made
Authorised by a resolution of Directors
under listing rule 4.5.1.


Terms or details of the issue (for example: restrictions, escrow
arrangements)
The shares will be credited as fully paid
ordinary shares in the Company and will
rank equally with the Company’s
existing Ordinary shares

Date of issue
2
16 December 2022
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Tony Wai
Contact person for this announcement Neil Hopkins
Contact phone number 021 760 745
Contact email address neil@thirdagehealth.co.nz
Date of release through MAP

16 December 2022




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).